Hospira Inc., A Pfizer Company recalls Levophed norepinephrine bitartrate, injection, USP, 4 mg /4 mL (1 mg/mL),Rx only, Hospira, Inc. Lake Forest, IL --- NDC…
- Recall date
- May 18, 2017
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0898-2017
- FDA classification
- Class II
- Brand / firm
- Hospira Inc., A Pfizer Company
- Sold / distributed
- Nationwide, Canada and Singapore
Why it was recalled
GMP Deviation; A foreign stopper was observed during packaging of a lot of product.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Levophed norepinephrine bitartrate, injection, USP, 4 mg /4 mL (1 mg/mL),Rx only, Hospira, Inc. Lake Forest, IL --- NDC 0409-3375-04
Get recall alerts
Free email alert whenever Hospira Inc., A Pfizer Company has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Hospira Inc., A Pfizer Company